Practice Test GeeksSQA - Society of Quality Assurance Practice Test
← All SQA Flashcard Decks

Regulatory Submissions and Compliance Flashcards

6 cards from real SQA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 Regulatory Submissions and Compliance flashcards as text

  1. What is the role of a 'Monitoring Authority' in the OECD GLP framework?

    Answer: A national authority responsible for inspecting test facilities to verify GLP compliance within that country

    Under OECD GLP, the Monitoring Authority is the national regulatory body (e.g., FDA in the US) that inspects test facilities to verify compliance.

  2. Which section of an NDA requires a summary of all GLP nonclinical pharmacology and toxicology studies?

    Answer: Module 4: Nonclinical Study Reports (CTD format)

    In the Common Technical Document (CTD) format, Module 4 contains all nonclinical study reports including GLP toxicology data.

  3. What does a 'Data Audit' by a regulatory agency such as the FDA typically involve during a GLP inspection?

    Answer: Comparing raw data to reported results in the final study report to verify accuracy and completeness

    Regulatory data audits trace data from original raw records to final reported values, verifying accuracy and detecting fabrication or manipulation.

  4. Under US GLP regulations, which agency has GLP oversight authority for pesticide studies submitted under FIFRA?

    Answer: U.S. Environmental Protection Agency (EPA)

    The EPA has GLP regulatory authority over nonclinical studies submitted under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).

  5. What is the purpose of a 'Compliance Status Letter' issued by an OECD Monitoring Authority to a GLP test facility?

    Answer: To certify that the test facility has been inspected and found to operate in compliance with GLP Principles

    Compliance Status Letters certify that a facility has undergone inspection and been found compliant with OECD GLP Principles, supporting mutual recognition of study data.

  6. Which regulatory pathway allows a sponsor to request FDA agreement on the acceptability of a nonclinical testing program before studies are conducted?

    Answer: Pre-IND meeting with FDA to discuss the nonclinical development plan

    Pre-IND meetings allow sponsors to align with FDA on the nonclinical testing program before committing resources to GLP studies.

How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. sqa.org — Score validity, registration, test delivery, eligibility, fees, exam format, late registration, passing score, retake fee, retake policy · verified Nov 2026